Asterion Cannabis Officially Listed on the Australian Department of Health and Office of Drug Control
pharmaceutical investing PreveCeutical Announces LOI with Crushedit LLC to Supply CBD Isolate for Expected Sale Proceeds of $16.25 Million
pharmaceutical investing PreveCeutical Provides Update on Visit to Penta 5 Group’s Facility for Due Diligence on Proposed Acquisition
pharmaceutical investing PreveCeutical Holds Intensive Workshop to Advance Dual Gene Therapy Research Program for Type 2 Diabetes and Obesity
cannabis investing PreveCeutical Enters into Development Agreement with Asterion Cannabis Inc. to Develop Medicinal Cannabinoid Products
cannabis investing Asterion Enters Consulting Agreement with White Sheep Services Corp. and Appoints Hamish Sutherland as COO
